1
Chen A, Chen HT, Chen HC, et al. Asymptomatic Meibomian Gland Dysfunction and Cardiovascular Disease Risk Factors in a Middle-Aged Population in Taiwan - A Cross-sectional Analysis. Sci Rep. 2017;7(1):4935.
2
Chao AS, Chang YL, Chao A, et al. Seropositivity of influenza A H1NI in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic. Taiwan J Obstet Gynecol. 2017;56(1):37-40.
3
Tseng JR, Chang YH, Yang LY, et al. Potential usefulness of (68)Ga-citrate PET/CT in detecting infected lower limb prostheses. EJNMMI Res. 2019;9(1):2.
4
Lin G, Yang LY, Lin YC, et al. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy. Eur Radiol. 2019;29(2):556-565.
5
Liao CT, Lee LY, Hsueh C, et al. Tumor Depth of Invasion (Tumor > 4 cm/Depth > 10 mm and Depth > 20 mm) and Through Cortex/Skin Invasion are Both Valid Criteria for Classifying Tumors as pT4a in AJCC 2018 Oral Cavity Cancer Staging System. Ann Surg Oncol. 2019;26(11):3663-3672.
6
Liao CT, Hsieh CH, Fan WL, et al. A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2019.
7
Lai YC, Yeh TS, Wu RC, et al. Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation. Cancers (Basel). 2019;11(5).
8
Lai CH, Vallikad E, Lin H, et al. Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group. J Gynecol Oncol. 2019;31(1):e5.
9
Huang YT, Yang LY, Pan YB, et al. Learning Curve Analysis of Transvaginal Natural Orifice Adnexal Surgery. J Minim Invasive Gynecol. 2019.
10
Huang YH, Chen ST, Liu FH, et al. The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial. PLoS One. 2019;14(8):e0221199.